TippingPoint Biosciences
Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer
$4.5MSeed
Role not disclosedLoading investors…
Activity from announced rounds
Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer
AI-native operating system for healthcare practices to automate back office functions
Pitching Sazze Partners? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room